You have 9 free searches left this month | for more free features.

prednisone alone

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Idiopathic Membranous Nephropathy Trial in Beijing (Prednisone, MP and CTX)

Terminated
  • Idiopathic Membranous Nephropathy
  • Beijing, China
    Beijing Friendship Hospital, Capital Medical University
Feb 2, 2022

Peripheral T Cell Lymphoma Trial in Harlingen (Belinostat Injection, Pralatrexate Injection, CHOP)

Not yet recruiting
  • Peripheral T Cell Lymphoma
  • Belinostat Injection
  • +3 more
  • Harlingen, Texas
    Valley Cancer Associates
Oct 16, 2023

Androgen-Independent Prostatic Cancer, Androgen-Independent Prostatic Tumors, Prostate Cancer Recurrent Trial (lorigerlimab,

Not yet recruiting
  • Androgen-Independent Prostatic Cancer
  • +8 more
  • lorigerlimab
  • +2 more
  • (no location specified)
May 4, 2023

Advanced Soft-tissue Sarcoma Trial in Nicosia, Amman (Doxorubicin, Cyclophosphamide Oral Product, Prednisolone)

Recruiting
  • Advanced Soft-tissue Sarcoma
  • Nicosia, Cyprus
  • +1 more
Jul 1, 2022

DLBCL Trial in Houston (Acalabrutinib, Cyclophosphamide, Doxorubicin Hydrochloride)

Recruiting
  • Diffuse Large B-Cell Lymphoma
  • Houston, Texas
    M D Anderson Cancer Center
Jul 10, 2022

Ann Arbor Stage I Primary Mediastinal (Thymic) Large B-Cell Lymphoma, Ann Arbor Stage II Primary Mediastinal (Thymic) Large

Recruiting
  • Ann Arbor Stage I Primary Mediastinal (Thymic) Large B-Cell Lymphoma
  • +3 more
  • Brentuximab Vedotin
  • +6 more
  • Houston, Texas
    M D Anderson Cancer Center
Feb 10, 2022

Treatment-na?ve Mantle Cell Lymphoma Trial in China (Orelabrutinib and R-CHOP, R-CHOP)

Not yet recruiting
  • Treatment-naїve Mantle Cell Lymphoma
  • Hefei, Anhui, China
  • +21 more
Dec 8, 2021

Hormone Refractory Prostate Cancer Trial in United States (LBH589)

Terminated
  • Hormone Refractory Prostate Cancer
  • Boston, Massachusetts
  • +4 more
Dec 16, 2020

Prostate Cancer Trial in Canada (Docetaxel, Reolysin and Prednisone, Docetaxel and Prednisone)

Completed
  • Prostate Cancer
  • Docetaxel, Reolysin and Prednisone
  • Docetaxel and Prednisone
  • Calgary, Alberta, Canada
  • +10 more
Apr 6, 2020

Follicular Lymphoma, Lymphoma, Follicular Trial in United States (Zevalin Therapeutic Regimen, R-CVP)

Terminated
  • Follicular Lymphoma
  • Lymphoma, Follicular
  • Zevalin Therapeutic Regimen
  • R-CVP
  • Jacksonville, Florida
  • +5 more
Dec 16, 2021

Prostate Cancer Trial in Worldwide (Nivolumab, Ipilimumab, Cabazitaxel)

Active, not recruiting
  • Prostate Cancer
  • Nivolumab
  • +3 more
  • Tucson, Arizona
  • +59 more
Dec 22, 2022

Prostate Cancer Trial in Canada, United States (custirsen sodium, docetaxel, prednisone)

Completed
  • Prostate Cancer
  • custirsen sodium
  • +2 more
  • Seattle, Washington
  • +12 more
Apr 6, 2020

Ann Arbor Stage III DLBCL, Ann Arbor Stage IIX (Bulky) DLBCL, Ann Arbor Stage IV DLBCL Trial in United States (drug, other,

Suspended
  • Ann Arbor Stage III Diffuse Large B-Cell Lymphoma
  • +20 more
  • Tucson, Arizona
  • +110 more
Jan 31, 2023

Langerhans Cell Histiocytosis of Bone Trial in Shanghai (Prednisone)

Recruiting
  • Langerhans Cell Histiocytosis of Bone
  • Shanghai, Shanghai, China
    Shanghai Changzheng Hospital
Oct 15, 2023

Duchenne Muscular Dystrophy (DMD) Trial in Gainesville (Prednisone, In-home Exercise Training, Prednisone plus exercise)

Recruiting
  • Duchenne Muscular Dystrophy (DMD)
  • Gainesville, Florida
    University of Florida
Feb 28, 2022

Biochemically-relapsing Prostate Adenocarcinoma Following Radical Prostatectomy Trial in France (Abiraterone)

Completed
  • Biochemically-relapsing Prostate Adenocarcinoma Following Radical Prostatectomy
  • Bordeaux, France
  • +4 more
May 18, 2022

Prostate Adenocarcinoma, Recurrent Prostate Carcinoma Trial in Houston (Abiraterone Acetate, Bicalutamide, Degarelix)

Active, not recruiting
  • Prostate Adenocarcinoma
  • Recurrent Prostate Carcinoma
  • Abiraterone Acetate
  • +7 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 5, 2022

Prostate Cancer Trial in Honolulu (Denosumab, Enzalutamide, Abiraterone)

Terminated
  • Prostate Cancer
  • Denosumab
  • +3 more
  • Honolulu, Hawaii
    University of Hawaii Cancer Center
Nov 6, 2019

Multiple Myeloma Trial in Torino (velcade subcutaneous melphalan prednisone, velcade cyclophosphamide prednisone, velcade

Active, not recruiting
  • Multiple Myeloma
  • velcade subcutaneous melphalan prednisone
  • +2 more
  • Torino, Italy
    A.O.U. Città della Salute e della Scienza di Torino - SC Ematolo
Mar 24, 2022

Lymphoma, Adult T-Cell Leukemia/Lymphoma, Lymphatic Diseases Trial in Hollywood, Boston, Chapel Hill (Brentuximab Vedotin, CHEP)

Active, not recruiting
  • Lymphoma
  • +2 more
  • Brentuximab Vedotin
  • CHEP
  • Hollywood, Florida
  • +3 more
Nov 30, 2022

Inflammatory Arthritis, Immune-related Adverse Event Trial (Adalimumab, Prednisone)

Not yet recruiting
  • Inflammatory Arthritis
  • Immune-related Adverse Event
  • (no location specified)
Sep 13, 2023

Metastatic Castrate Sensitive Prostate Cancer Trial in Worldwide (Niraparib, Abiraterone acetate (AA), Prednisone)

Recruiting
  • Metastatic Castrate Sensitive Prostate Cancer
  • Homewood, Alabama
  • +439 more
Jan 17, 2023

Metastatic Prostate Carcinoma, Recurrent Prostate Carcinoma, Stage IV Prostate Cancer Trial in Sacramento (Abiraterone Acetate,

Active, not recruiting
  • Metastatic Prostate Carcinoma
  • +2 more
  • Abiraterone Acetate
  • +2 more
  • Sacramento, California
    University of California Davis Comprehensive Cancer Center
Feb 23, 2022

ANCA-associated Vasculitis, Maintenance Therapy Trial in Beijing (Azathioprine, Telitacicept)

Recruiting
  • ANCA-associated Vasculitis
  • Maintenance Therapy
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
Jul 20, 2023

Prostate Cancer Trial in United States (Abiraterone acetate, Abiraterone acetate plus degarelix, Degarelix)

Completed
  • Prostate Cancer
  • Abiraterone acetate
  • +2 more
  • Chicago, Illinois
  • +15 more
Oct 25, 2021